← Alle Beiträge

Dieser Artikel ist noch nicht in Ihrer Sprache verfügbar, daher zeigen wir das englische Original.

Which address goes in the EUDAMED eIFU URL field?

The MDR marks the EUDAMED URL field optional. If your IFU is electronic, Article 7(3) of Regulation 2021/2226 makes it mandatory and names the address.

eIFU Regulation · MDR · IVDR

In the UDI-DI identification step in EUDAMED there is a line asking for a URL “if applicable” for additional information online. The help page does not say what kind of URL. The user guide has no field for electronic instructions at all. It is easy to leave the line empty, or to paste in the company homepage and move on.

If your instructions for use are electronic, neither is a good idea. The regulation that allows electronic instructions has a paragraph about this exact field. It makes the field mandatory and says which address belongs in it. It also expects that address to work for at least ten years after the last device is placed on the market. Let’s find out what it says, and whether a search page will do.

What the field is

The line on the form comes from the MDR’s list of data you file against every UDI-DI. Point 22 of that list reads “URL for additional information, such as electronic instructions for use (optional)” (Annex VI, Part B, point 22). The IVDR has the same line, with the same optional marking, at point 19 of its own list (Annex VI, Part B, point 19).

So the field is wider than electronic instructions, which are only the example the drafters chose. And on its own, it is optional.

Why it stops being optional

Regulation (EU) 2021/2226 sets the conditions for supplying the instructions of an MDR device for professional users in electronic form instead of on paper. Since 16 July 2025 it has contained a sentence that ends (Article 7(3)): ”… the manufacturer shall provide the internet address referred to in paragraph (2), point (e), of this Article to the UDI database in accordance with Part B, point 22, of Annex VI to Regulation (EU) 2017/745.”

The optional marking describes the field in general. Article 7(3) is a duty on you if your instructions replace paper. That includes instructions supplied on a storage medium, shown by the device itself, or provided through software, because in every case the instructions must also be available on your website (Article 5(11)).

For a manufacturer using electronic instructions, the optional field is a duty.

The duty exists only under the MDR. Regulation 2021/2226 does not apply to in vitro diagnostics. Their manufacturers may supply non-paper instructions for devices intended for professional use only, other than near-patient tests, under Annex I of the IVDR instead (Section 20.1(f)). Nothing on the IVD side requires filing an address, so point 19 stays optional in every case.

Which address

Article 7(3) does not ask for a link of your choosing. It points back to Article 7(2)(e), which points back to Article 6(2).

ProvisionWhat it says
Article 6(2)You give the user information on how to access the electronic instructions, on the packaging or, if that is not practicable, in a paper document with the device.
Article 7(2)(e)The internet address displayed under Article 6(2) must be stable and directly accessible for the retention period.
Article 7(3)That address is the one you file in point 22.

The value of the field is therefore the address you give the user with the device. The same string sits on the packaging and in the UDI-DI record.

The address filed in EUDAMED is the one you give the user with the device.

For how long, and by when

The retention period is the one in Article 5. For devices with an expiry date, other than implants, the instructions stay available for 10 years after the last device was placed on the market. They also stay available for at least 2 years after the end of the expiry date of the last device produced (Article 5(9)). For implants and for devices without an expiry date, it is 15 years after the last device was placed on the market (Article 5(10)). The address has to survive every website redesign and domain change in that time. Once filed, it is public data that you must verify periodically and update within 30 days of a change (Annex VI, Part C, Sections 5.4 and 5.8).

The deadline follows the EUDAMED registration deadlines. The Commission’s notice that started the clock was published on 27 November 2025.

  • Devices first placed on the market from 28 May 2026. You register before placing on the market (Article 29(1)), so the address is part of the record from day one (Article 123(3)(d)).
  • Devices already on the market before that date and still being placed on it. The registration data must be in by twelve months from the notice, that is 27 November 2026 (Article 123(3)(e)). The two dates differ by a day because the provisions are worded differently. The six-month rule says obligations apply from a date, while this one sets a deadline of no later than twelve months. Devices sold under the Article 120 transitional provisions are expressly included.

Can the address be a search page?

A manufacturer may print one address for the whole product range, with the user finding the right document on arrival by entering a UDI or a catalogue number. Whether that is “directly accessible” is not settled. The phrase dates from Regulation 207/2012, which applied from 1 March 2013. In thirteen years neither the Commission nor the MDCG has defined it, as far as we have found.

Our reading is that a search page is allowed, for three reasons. The adjectives in Article 7(2)(e) describe the address: it has to stay the same and it has to resolve. The access information you give the user must already include the Basic UDI-DI and/or the UDI-DI of the device (Article 6(3)). That requirement sits naturally with a user who uses the identifier on arrival. And nothing in the regulation limits the number of steps between the address and the document.

The other reading is that “directly accessible” describes the instructions, and a search page is a step in the way. It is a fair reading of the purpose. We do not take it, because the words do not say it.

Either way, the real test sits in Articles 4 and 5. Your risk assessment has to cover the users and their environment, and their familiarity with and access to the hardware and software needed to display the instructions. It also has to cover what happens when the website is temporarily unavailable (Article 4(1)). You also have to provide verification and validation evidence that the electronic instructions are properly designed and function (Article 5(5)). A search page is a design choice, so it belongs in both. The question a notified body can put to you is simple: does a user in the real setting complete the search and reach the right version?

For comparison, the Australian TGA says an IFU available only online “must be easy to locate from the manufacturer’s homepage or a simple web search”, and should not sit behind an account or password. That is not EU law, but it shows a regulator thinking in terms of locating rather than landing.

A homepage with no route to the instructions fails on any reading. So, on our reading, does a login wall.

One address, three places

Article 7(3) names the address you display to the user. So you cannot, on our reading, print a generic address on the pack and then file a different, device-specific link in EUDAMED. The field takes the displayed address, and the search page then has to do the work.

The simplest arrangement removes the question. Give each device its own address. Then the packaging, the website and the EUDAMED record all point to the same place. Ydntfy offers both: a device-specific address for each device, and a search page for the generic case. You can build the same thing on your own site.

If your instructions are on paper

Then there is no Article 7(3) and the field is what the MDR says it is: optional. It can still be useful, and it still has consequences.

The best candidate for it is a page you already owe. Annex I requires the information supplied with the device to be available and kept up to date on your website, if you have one (Annex I, Section 23.1). A device page with the label and instruction content, data sheets and reprocessing instructions is a natural fit. Whatever you file becomes public (Article 28(3)) and has to be kept correct, and the page it points at stays subject to the ban on misleading claims (Article 7). We would keep campaign pages and tracking links out of it.

One last point, for manufacturers who put their paper instructions online as well. Those count as instructions in electronic form (Article 2(1)), but the conditions in Articles 3 to 7, including Article 7(3), apply only where the electronic form replaces paper. Since 16 July 2025 an online copy beside paper carries one requirement under this regulation: it must be consistent with the paper (Article 9). The paragraph that once applied some of the website conditions to it, including the stable address, was deleted. The paper still goes in the box, and the address of the online copy does not have to be filed anywhere.

Publishing the paper instructions online does not make them instructions supplied instead of paper.

Sources

Primary sources. Every claim in this post is traceable to one of these, and the sub-provision detail sits here rather than in the body.

Show 11 sources

About this post

Ydntfy runs electronic instructions for use for medical device and IVD manufacturers, built to the conditions in Articles 4 to 7 of Regulation (EU) 2021/2226 for devices under the MDR and to Annex I, Section 20.1(f) of the IVDR for in vitro diagnostics. You can see how it works at ydntfy.com.

Originally published at https://ydntfy.com/en/blog/eudamed-eifu-url-field/ on 3 September 2026. You are welcome to quote or reuse this, with a link back.